101 related articles for article (PubMed ID: 2455265)
1. Transforming activity of ras proteins translocated to the plasma membrane by a myristoylation sequence from the src gene product.
Lacal PM; Pennington CY; Lacal JC
Oncogene; 1988 Jun; 2(6):533-7. PubMed ID: 2455265
[TBL] [Abstract][Full Text] [Related]
2. Novel determinants of H-Ras plasma membrane localization and transformation.
Willumsen BM; Cox AD; Solski PA; Der CJ; Buss JE
Oncogene; 1996 Nov; 13(9):1901-9. PubMed ID: 8934536
[TBL] [Abstract][Full Text] [Related]
3. Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity.
Der CJ; Cox AD
Cancer Cells; 1991 Sep; 3(9):331-40. PubMed ID: 1751286
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of p21 ras proteins.
Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterisation of the protein encoded by the activated human N-ras gene and its membrane localisation.
Grand RJ; Smith KJ; Gallimore PH
Oncogene; 1987; 1(3):305-14. PubMed ID: 3133625
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
Min S; Mascarenhas NT; Taparowsky EJ
Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
[TBL] [Abstract][Full Text] [Related]
7. Activation of the cellular proto-oncogene product p21Ras by addition of a myristylation signal.
Buss JE; Solski PA; Schaeffer JP; MacDonald MJ; Der CJ
Science; 1989 Mar; 243(4898):1600-3. PubMed ID: 2648572
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of the C-terminal hypervariable region of K-Ras4B in plasma membrane targetting and transformation.
Welman A; Burger MM; Hagmann J
Oncogene; 2000 Sep; 19(40):4582-91. PubMed ID: 11030147
[TBL] [Abstract][Full Text] [Related]
9. The ras/cholesterol connection: implications for ras oncogenicity.
Cox AD; Der CJ
Crit Rev Oncog; 1992; 3(4):365-400. PubMed ID: 1420445
[TBL] [Abstract][Full Text] [Related]
10. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
11. Function, location, and regulation of the src protein-tyrosine kinase.
Varmus H; Hirai H; Morgan D; Kaplan J; Bishop JM
Princess Takamatsu Symp; 1989; 20():63-70. PubMed ID: 2484925
[TBL] [Abstract][Full Text] [Related]
12. The defective transforming phenotype of c-Jun Ala(63/73) is rescued by mutation of the C-terminal phosphorylation site.
Bost F; Caron L; Vial E; Montreau N; Marchetti I; Dejong V; Defize L; Castellazzi M; Binétruy B
Oncogene; 2001 Nov; 20(50):7425-9. PubMed ID: 11704873
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 32K plasma membrane protein that binds to the myristylated amino-terminal sequence of p60v-src.
Resh MD; Ling HP
Nature; 1990 Jul; 346(6279):84-6. PubMed ID: 2164157
[TBL] [Abstract][Full Text] [Related]
14. Protection against malignant conversion in SENCAR mouse skin by all trans retinoic acid: inhibition of the ras p21-processing enzyme farnesyltransferase and Ha-ras p21 membrane localization.
Agarwal R; Mohan RR; Ahmad N; Mukhtar H
Mol Carcinog; 1996 Sep; 17(1):13-22. PubMed ID: 8876671
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
Pullano TG; Sinn E; Carney WP
Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
[TBL] [Abstract][Full Text] [Related]
16. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
Potts WM; Reynolds AB; Lansing TJ; Parsons JT
Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
[TBL] [Abstract][Full Text] [Related]
17. Transformation by p60src with altered N-terminal sequences.
Hanafusa H; Garber EA; Hanafusa T
Princess Takamatsu Symp; 1986; 17():233-40. PubMed ID: 2843496
[TBL] [Abstract][Full Text] [Related]
18. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ
Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579
[TBL] [Abstract][Full Text] [Related]
19. Separation of immortalization and T24-ras oncogene cooperative functions of adenovirus E1a.
Kuppuswamy M; Subramanian T; Chinnadurai G
Oncogene; 1988 Jun; 2(6):613-5. PubMed ID: 2968534
[TBL] [Abstract][Full Text] [Related]
20. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
